Progress with biological agents in metastatic colorectal cancer leads to many challenges
- PMID: 16849745
- DOI: 10.1200/JCO.2006.06.2067
Progress with biological agents in metastatic colorectal cancer leads to many challenges
Comment on
-
Phase II multicenter trial of bevacizumab plus fluorouracil and leucovorin in patients with advanced refractory colorectal cancer: an NCI Treatment Referral Center Trial TRC-0301.J Clin Oncol. 2006 Jul 20;24(21):3354-60. doi: 10.1200/JCO.2005.05.1573. J Clin Oncol. 2006. PMID: 16849749 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
